基于mRNA的癌症疫苗:对当前情景和未来前景的回顾
Sanchari Bhattacharya1, Nilufa Easmin1, Atanu Panja1
1Department of Pharmacy, Guru Nanak Institute of Pharmaceutical Science and Technology, 157/F, Nilgunj Road, Panihati, Kolkata, 700114, India.
使者RNA (mRNA) 疗法在癌症治疗方面表现有前途,利用脂质纳米粒子 (LNP) 技术. 克服mRNA稳定性和传递方面的挑战是释放其在癌症免疫治疗中的全部潜力的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 使者RNA (mRNA) 正在成为一种强大的治疗方式,特别是在癌症治疗中.
- 使用脂质纳米粒子 (LNP) 技术对抗COVID-19的mRNA疫苗的成功刺激了对瘤学mRNA的兴趣.
- mRNA在癌症免疫治疗中提供了多方面的应用,包括疫苗和工程T细胞.
研究的目的:
- 审查基于mRNA的癌症疗法的当前进展和未来方向.
- 探索mRNA癌症治疗的各种传递途径和治疗平台.
- 提供有关最新的基于mRNA的癌症免疫疗法的见解.
主要方法:
- 对基于mRNA的癌症免疫疗法的现有文献的综述.
- 分析不同的mRNA治疗策略,包括疫苗和工程蛋白质.
- 对基于纳米粒子的mRNA药物输送系统的检查.
主要成果:
- mRNA可以用于针对瘤抗原的癌症疫苗,以及设计具有仿真抗原受体 (CAR) 的T细胞.
- 需要解决mRNA不稳定性,免疫性和低效的体外输送等局限性.
- 包括LNP在内的纳米粒子平台对于提高mRNA药物输送和治疗效果至关重要.
结论:
- 基于mRNA的癌症免疫疗法具有显著的治疗潜力,但需要克服传递和稳定性挑战.
- 个性化mRNA疫苗和工程免疫调节蛋白质代表了有希望的未来方向.
- 先进的纳米粒子输送系统对于优化基于mRNA的癌症治疗至关重要.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
相关概念视频
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
